is semaglutide compound effective FDA Warns on Certain Forms of Compounded Compounded GLP-1 - Semaglutide &

Over a 48-week trial in adults with obesity but no diabetes, the highest tested dose of 12 mg once weekly produced an average 24.2% reduction in body weight , compared with just over 2% in the placebo group

Glucagon receptor antagonism and lipid metabolism. Diabetes Obes Metab , 2016

However, when balanced with GLP-1 and GIP activation, the net metabolic effect may favour fat oxidation and weight reduction

Clinical trial subgroup analyses consistently show that participants with a BMI of 35 or higher lose a larger percentage of body weight than those with lower BMIs

Current non-clinical and preclinical investigations continue to examine its potential role in metabolic pathways [1]

The April 30, 2026 FDA proposal would further close the 503B bulks pathway permanently